Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-005495
Filing Date
2020-06-09
Accepted
2020-06-09 16:05:17
Documents
1
Period of Report
2020-06-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-49011.html 4  
1 PRIMARY DOCUMENT marketforms-49011.xml 4 3119
  Complete submission text file 0001214659-20-005495.txt   4462
Mailing Address 388 GREENWICH STREET, 17TH FLOOR NEW YORK NY 10013
Business Address
Humer Franz B (Reporting) CIK: 0001548072 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38693 | Film No.: 20951847

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)